Table 4 Mean annual diabetes-associated cost per patient in the study population with different cost categories, stratified by age group
From: Healthcare expenditure and technology use in pediatric diabetes care
|  | 0 (n = 6) | 1–5 (n = 336) | 6–10 (n = 1,119) | 11–15 (n = 2,528) | 16–17 (n = 1,485) | p |
|---|---|---|---|---|---|---|
Diabetes-associated costs | € 4,239 (671—5,502) | € 8,285 (1,885—11,530) | € 6,564 (2,281—9,036) | € 4,941 (1,673—6,493) | € 3,708 (1,252—4,904) |  < 0.001 |
Consultation costs (%) | 9.6 | 12.4 | 16.7 | 21.6 | 26.7 |  < 0.001 |
Clinical costs (%) | 6.1 | 17.8 | 9.7 | 12.1 | 11.0 |  < 0.001 |
Treatment costs (%) | 70.8 | 65.0 | 68.9 | 59.9 | 55.1 |  < 0.001 |
Diagnostic costs (%) | 13.5 | 4.8 | 4.7 | 6.4 | 7.2 |  < 0.001 |
Additional costs (%) | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.757 |